High-Quality CTLA-4 Inhibitor (CAS: 635324-72-0) – Available at Finetech Industry Limited

🔬 Advancing Immunotherapy Research with CTLA-4 Inhibitors 🔬At Finetech Industry Limited, we are committed to providing high-purity research chemicals for cutting-edge scientific advancements. One of our key offerings is CTLA-4 Inhibitor (CAS: 635324-72-0), a promising compound in the field of immunotherapy and oncology research.Product Details🔹 Chemical Name: 2-(4-fluorophenyl)-6-methyl-4-(3-(trifluoromethyl)phenyl)-1,2-dihydrodipyrazolo[3,4-b:3',4'-d]pyridin-3(6H)-one🔹 CAS Number: 635324-72-0🔹 Purity: High-purity, research-grade🔹 Application: Immuno-oncology, autoimmune disease research, and [...]

Introduction of product 9-Methoxy-9-borabicyclo[3.3.1]nonane,38050-71-4

9-Methoxy-9-borabicyclo[3.3.1]nonane,38050-71-4 commonly known as B-Methoxy-9-BBN, is a versatile and valuable reagent in organic synthesis. This compound belongs to the family of boron-organic compounds and is widely used in various chemical reactions due to its unique properties. In this article, we will explore the structure, synthesis, reactivity, and applications of 9-Methoxy-9-borabicyclo[3.3.1]nonane in organic chemistry.Structure:9-Methoxy-9-borabicyclo[3.3.1]nonane is a bicyclic compound consisting of a boron atom and a bicyclic framework. The boron atom is attach [...]

Methyl 2,5,6-Trichloropyrimidine-4-carboxylate,Cas:89284-85-5: A Versatile Chemical Compound

Methyl 2,5,6-Trichloropyrimidine-4-carboxylate 89284-85-5: A Versatile Chemical Compound | Available at Finetech Industry LimitedIntroduction:Methyl 2,5,6-trichloropyrimidine-4-carboxylate is a chemical compound known for its versatility and wide-ranging applications. At FINETECH Industry Limited, we offer this compound to meet the diverse needs of industries. This article provides an overview of methyl 2,5,6-trichloropyrimidine-4-carboxylate, including its structure, synthesis methods, and potential applications, highlighting how you can contact us for your requirements.Chemical Structure:Met [...]